Life Science Investing

Cara Therapeutics Tumbles on Phase 2 Oral KORSUVA Results

Biotech Investing

Cara Therapeutics Announces Results from Phase 2 Trial of KORSUVA

Biotech Investing

Lexicon Pharmaceuticals Completes a Safety Review in TELE-ABC

Biotech Investing

MediWound Begins Phase 2 Adaptive Design Study of EscharEx

Biotech Investing

Outlook Therapeutics Receives FDA Agreement for Special Protocol Assessments

Biotech Investing

Atreca Receives FDA Clearance of IND Application for ATRC-101

Biotech Investing

Adaptimmune Therapeutics Receives Advanced Therapy Designation

Biotech Investing

Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to Its Board of Directors

Cannabis Investing News

Eton Pharmaceuticals Announces Availability of Biorphen Injection

Pharmaceutical Investing

BrainsWay Announces Results in Pivotal Multicenter Study

Medical Device Investing

Neurocrine and Xenon to Develop Treatments for Epilepsy

Biotech Investing

Akari Therapeutics Announces Phase 3 Trial Design

Biotech Investing

Latest life science News

More life science News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES